Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Vessel Dilation Device Advances Peripheral Artery Interventions

By HospiMedica International staff writers
Posted on 17 Mar 2017
A novel dilation balloon creates multiple longitudinal micro-serrations in order to help the expansion of blood vessels in peripheral artery disease (PAD).

The Cagent Vascular Serranator Alto combines mechanical percutaneous transluminal angioplasty (PTA) balloon dilatation and multiple serrated scoring elements in order to create linear, interrupted scoring along the endoluminal surface of peripheral arteries. More...
The teeth-like ridges are located on four sides of the dilation balloon; as it is pumped with saline to expand a constricted vessel, the ridges create tiny serrations lines help guide the expansion of the arteries.

The Serranator Alto is intended for dilatation of PAD lesions in the iliac, femoral, iliofemoral, and popliteal arteries, as well as for the treatment of obstructive lesions of native or synthetic arteriovenous (AV) dialysis fistulae. The need for the device, according to the company, arises from an increasingly aging population, increased incidence of obesity, type-2 diabetes, smoking, and hypercholesterolemia, all of which contribute to an increased lesion complexity in PDA.

“A new approach to vessel dilatation is long overdue for treatment of diseased peripheral arteries; today we are treating more complex lesions that require better tools,” said vascular surgeon Peter Schneider, MD, co-founder and chief medical officer of Cagent Vascular. “We believe serration technology will prove to be effective in more complex lesions and will evolve into the new standard of care for vessel dilatation. In the future we hope to show clinical benefit as a vessel preparation tool with new technologies, such as drug coated balloons.”

“We have also begun the development of the Serranator Bass for treatment of the below-the-knee or infrapopliteal arteries, where new technologies are desperately needed for the treatment of critical limb ischemia,” said Carol Burns, CEO of Cagent Vascular. “Future applications of interest include serration technology for vessel preparation prior to the use of bioresorbable scaffolds in coronary arteries.”

PAD results when the peripheral arteries become too narrow or obstructed due to plaque, limiting blood flow to the legs. If left untreated, it can cause pain or aching in the legs, difficulty with walking, resting pain in the foot at night while lying down, and non-healing sores or infections in the toes or feet; PAD can ultimately lead to limb loss in its most severe form. In addition, it can be associated with other serious arterial conditions that can lead to heart attacks and stroke.


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.